NasdaqGS:OPKHealthcare
OPKO Deepens Nicoya Alliance As RAYALDEE China Prospects Draw Focus
OPKO Health (NasdaqGS:OPK) has expanded its alliance with Nicoya Therapeutics to advance the commercialization of RAYALDEE in Greater China.
The amended agreement gives OPKO an equity interest in Nicoya Therapeutics and a deeper collaborative role in the partnership.
The move focuses on driving regulatory progress and commercial preparation for RAYALDEE in a region with significant renal health needs.
OPKO Health focuses on diagnostics and pharmaceuticals, with RAYALDEE positioned for...